scispace - formally typeset
Search or ask a question

What is the role of epigenetics in the development of cancer? 


Best insight from top research papers

Epigenetics plays a crucial role in the development of cancer. Mutations or abnormal expression of oncogenes and tumor suppressor genes are known to cause cancer, but recent studies have shown that epigenetic modifications are also key drivers of cancer development and progression . Epigenetic changes, such as DNA methylation and histone modifications, regulate gene expression without altering the primary DNA sequence. These changes can cooperate with genetic alterations to drive the cancer phenotype . The plasticity of cancer cell phenotypes is a result of stochastic changes in the epigenetic landscape, which can be quantitatively mapped onto phenotypic outcomes . Epigenetic dysregulation in the tumor microenvironment is also important, as it affects both cancer cells and non-cancer cells . Understanding the role of epigenetics in cancer development is crucial for the development of epigenetic drugs and the comprehensive treatment of cancer .

Answers from top 4 papers

More filters
Papers (4)Insight
Book ChapterDOI
01 Jan 2023
Epigenetic changes cooperate with genetic alterations to drive the development of cancer.
Epigenetics plays a role in the development of cancer by influencing gene expression and altering the activity of genes involved in cell growth and division.
Epigenetic modifications are key drivers of cancer development and progression, playing a crucial role in the tumor microenvironment.
Epigenetics plays a role in the development of cancer by altering gene expression without changing the DNA sequence.

Related Questions

How does epigenetic modifications effect cancer?5 answersEpigenetic modifications play a crucial role in cancer development and progression. These modifications, including DNA methylation, histone modifications, and non-coding RNAs (ncRNAs), can alter gene expression without changing the DNA sequence. Aberrations in epigenetic processes are reversible, making them potential targets for novel pharmacological treatments. Epigenetic drugs (epidrugs) have shown promise in reversing drug resistance in cancer patients. The dysregulation of epigenetic mechanisms, particularly DNA methylation, is commonly observed in various cancers and can lead to sustained proliferative potential, resistance to growth-suppressive signals, and metastasis. Targeting DNA methylation dynamics through small molecules that regulate DNA-modifying enzymes, such as DNA methyltransferases (DNMTs) and ten-eleven translocation (TET) enzymes, has emerged as a potential therapeutic option. Understanding the epigenetic mechanisms related to cancer can lead to the development of novel therapeutic approaches and biomarkers for early diagnosis. Additionally, epigenetic modifications are involved in the non-targeted effects of ionizing radiation, which have implications for radiotherapy and radioprotection.
What is the role of epigenetics in the development and progression of cancer?5 answersEpigenetics plays a crucial role in the development and progression of cancer. Mutations or abnormal expression of oncogenes and tumor suppressor genes are known to cause cancer, but recent studies have shown that epigenetic modifications are also key drivers of cancer development and progression. Epigenetic dysregulation in the tumor microenvironment, both in cancer cells and non-cancer cells, is essential for understanding cancer etiology and plasticity of cancerous states. Epigenetic changes, such as DNA methylation and histone modifications, can lead to alterations in gene expression and chromatin structure, contributing to the development of cancer. The plasticity of cancer cell phenotypes, driven by epigenetic changes, allows cancer cells to adopt increased structural and functional plasticity, leading to tumor progression and metastasis. Understanding the epigenetic landscape of cancer cells can provide insights into the heterogeneity of cancer and identify potential therapeutic targets. Overall, epigenetic modifications in the tumor microenvironment are crucial for the development of epigenetic drugs and the comprehensive treatment of cancer.
WHAT IS epigenetics in breast cancer onset and development?5 answersEpigenetic modifications, which involve changes in gene expression without altering the DNA sequence, play a crucial role in the onset and development of breast cancer. These modifications can be reversible and are influenced by both genetic and environmental factors. Epigenetic alterations, such as DNA methylation, histone modifications, and post-transcriptional silencing of mRNA, have been implicated in breast cancer development and progression. They can regulate gene expression and contribute to tumor characteristics. Understanding the key epigenetic modulations in breast cancer is important for targeted therapy. Epigenetic-targeting drugs, including DNA methyltransferase inhibitors, histone deacetylase inhibitors, and miRNA regulators, have shown promise in reversing these alterations and may be used in combination with conventional therapies for more effective treatment. The reversibility of epigenetic changes makes them attractive targets for breast cancer management. Overall, epigenetic modifications are critical in breast cancer and offer potential avenues for developing robust therapies.
What is the role of epigenetics in evolution?5 answersEpigenetics plays a significant role in evolution by influencing gene expression, phenotypic plasticity, and the production of different phenotypes from the same genome. Epigenetic mechanisms, such as DNA methylation and histone modifications, can be inherited and affect the phenotype of offspring. Epigenetic changes can alter evolutionary dynamics, with adaptation initially happening via epigenetic changes and later being replaced by genetic mutations. Epigenetic variation enhances phenotypic plasticity and phenotypic variance, modulating the effect of natural selection on genetic variation. Epigenetic processes, particularly DNA methylation, contribute directly to DNA sequence evolution and genome stability. Epigenetic variation can also contribute to adaptation, domestication, and speciation. Overall, epigenetics provides a mechanism for heritable variation and phenotypic plasticity, influencing evolutionary processes.
What is relationship between epigenetics and cancer?5 answersEpigenetics plays a crucial role in cancer development and progression. Epigenetic changes, such as DNA methylation and histone modifications, work in conjunction with genetic alterations to drive the cancer phenotype. The concept of an epigenetic landscape describes the potential cellular fates arising from pluripotent cells and has been applied to understand cancer etiology and the plasticity of cancerous states. Alterations in DNA methylation and histone modification patterns orchestrate tumor progression and metastasis, making them useful biomarkers for diagnosis, monitoring, and treatment choice in clinical settings. Epigenetic modulations of gene expression, post-transcriptional silencing of mRNA, and post-translational modifications of protein functions are key mechanisms in breast cancer and can be targeted for therapy. The reversibility of epigenetic modifications has made the epigenetic machinery an attractive target for drug development, with epigenetic drugs already approved by the FDA for the treatment of cancer patients.
How do epigenetic changes contribute to cancer development?5 answersEpigenetic changes contribute to cancer development by regulating gene expression programs that promote tumorigenesis. These changes include shifts in DNA methylation and histone mark patterns, which orchestrate tumor progression and metastasis. Epigenetic alterations cooperate with genetic changes to drive the cancer phenotype. They can occur through mechanisms such as DNA methylation, histone modifications, and noncoding RNA. Epigenetic modifications, including mutations and aberrant expression of chromatin-modifying enzymes, alter chromatin structure and dynamics, leading to changes in gene expression that contribute to cancer emergence and evolution. Epigenetic changes are observed in genes related to epithelial-mesenchymal transition (EMT), a process that promotes cancer progression and metastasis. Additionally, sphingolipids and factors in the tumor microenvironment, such as hypoxia and acidosis, can induce epigenetic modifications that support cancer growth and aggressiveness.

See what other people are reading

What is the impact of the GJA4 mutation on the development and progression of cancer??
4 answers
The GJA4 mutation has a significant impact on cancer development and progression. Research has shown that this mutation is associated with hypersensitivity to histone demethylase inhibitors like GSK-J4, leading to downregulation of cell-cycle progression genes and increased H3K27me3 levels. Additionally, the GJA4 mutation activates the SGK-1 signaling pathway, promoting cell hyperproliferation and loss of arterial specification, contributing to the development of vascular malformations like ECHs. These findings highlight the crucial role of the GJA4 mutation in altering gene expression, metabolic pathways, and cellular signaling, ultimately influencing cancer cell viability and progression. The GJA4 mutation emerges as a key player in cancer biology, offering insights into potential therapeutic targets for cancer treatment.
How do PDE-5 inhibitors affect iron status?
5 answers
PDE-5 inhibitors have varying effects on iron status. Studies show that chronic administration of PDE5 inhibitors like sildenafil and tadalafil can lead to significant reductions in red blood cell count, hemoglobin concentration, and other hematological parameters. However, upon withdrawal of treatment, these negative effects are reversed, with increases observed in red blood cell count and hemoglobin concentration. Additionally, PDE5 inhibitors have been found to impact biochemical changes associated with prothrombin time, platelet function, fibrinogen weight, and D-dimer levels. While the exact impact on iron status specifically is not directly addressed in the provided contexts, the hematological alterations induced by PDE-5 inhibitors suggest a potential indirect influence on iron metabolism.
What percentage of macrophage go into CNS?
5 answers
In the context of central nervous system (CNS) diseases, the infiltration of macrophages into the CNS varies depending on the specific condition. Studies have shown that in experimental herpes simplex virus 1 (HSV-1) encephalitis, the percentage of "Ly6C hi" inflammatory monocytes significantly increases in the CNS on day 6 post-infection, corresponding to more severe clinical signs of the disease. Additionally, in injured immature brain tissue after ischemia-reperfusion, the number of CD45+/CD11b+ cells, which represent invading monocytes, increases 3-fold in the injured brain tissue compared to uninjured tissue at 24 hours post-reperfusion. These findings suggest that macrophage infiltration into the CNS can be dynamic and context-dependent, with varying percentages observed in different CNS pathologies.
Why diet and nutrition affect Colorectal cancer risk?
6 answers
Diet and nutrition significantly affect colorectal cancer (CRC) risk due to a complex interplay of dietary components, lifestyle factors, and their impact on the gut microbiome and the body's metabolic and inflammatory processes. The Western diet, characterized by high intake of fat, red meat, and processed meat, has been identified as a major contributor to increased CRC risk. This diet pattern is associated with modifications in the gut microbiota that can lead to an unfavorable environment promoting colonic epithelial cell carcinogenesis. Conversely, diets rich in dietary fiber, fruits, and vegetables have been shown to exert protective effects against CRC. Dietary fibers and certain micronutrients, such as vitamin D, selenium, and calcium, can counteract the harmful effects of a high-fat diet by reducing intestinal transit time, diluting carcinogens, and providing antioxidants, which collectively contribute to a reduced risk of CRC. The gut microbiome plays a pivotal role in modulating the risk of CRC through its interaction with dietary components. Specific dietary patterns can influence the composition and metabolism of the gut microbiota, leading to the production of protective compounds or, conversely, mutagenic and carcinogenic agents. For instance, a healthy diet rich in vegetables, fruits, milk, and yogurt has been associated with a lower CRC risk, particularly in individuals with certain gut microbiota enterotypes. Moreover, dietary modifications, such as increased intake of whole grains, milk, and calcium, could potentially save a significant proportion of deaths and disability-adjusted life-years (DALYs) attributable to CRC. Emerging evidence suggests that dietary interventions, including adherence to dietary guidelines tailored for specific populations, can effectively reduce CRC risk. Additionally, the dietary inflammatory potential and an overall inflammatory profile, incorporating diet, physical activity level, and abdominal obesity, have been linked to higher CRC risk, especially among men and in colon cancer specifically. This underscores the importance of comprehensive lifestyle modifications, including diet, to mitigate CRC risk.
What are the molecular mechanisms behind epirubicin resistance in cancer cells?
5 answers
Epirubicin resistance in cancer cells involves intricate molecular mechanisms. Studies have highlighted several key factors contributing to this resistance, including dysregulation of long non-coding RNAs (lncRNAs) like NONHSAT101069, which promote resistance, migration, and invasion in breast cancer cells. Additionally, the upregulation of novel lncRNA lnc005620 has been associated with promoting triple-negative breast cancer progression and chemoresistance to epirubicin through integrin β1 modulation. Furthermore, the interplay between FOXM1, p53, E2F, and ATM has been identified as crucial in modulating epirubicin response and resistance in breast cancer, emphasizing the role of these proteins in coordinating FOXM1 expression. Understanding these molecular pathways is essential for developing effective strategies to overcome epirubicin resistance in cancer cells.
What are the studies about epi-markers/?
5 answers
Studies have focused on utilizing epi-markers for various purposes such as early detection of cancer, identifying individual risk scores in childhood obesity, and understanding the impact of epigenetic mechanisms on complex disorders. These markers include DNA methylation changes, histone modifications, and noncoding RNA functions, which play crucial roles in disease development and progression. Research has shown that epi-markers like CRP concentrations in saliva and DNA methylation patterns can serve as non-invasive methods for detecting risks of non-communicable diseases in children. Additionally, the development of assays like the "multiplex methylation specific-PCR (MMSP)" has enabled the detection of tumor-specific methylation status in various cancers, aiding in early diagnosis and potential therapeutic interventions. These studies highlight the significance of epi-markers in disease management and prevention.
What is the association of nutrition and drug abuse?
5 answers
Nutrition plays a crucial role in the context of drug abuse. Substance abuse can lead to alterations in food preferences and dietary habits, impacting an individual's nutritional status. Substance users are at high risk of nutritional deficiencies due to hormonal alterations affecting appetite and eating patterns, as well as changes in nutrient absorption and metabolism. Drug-nutrient interactions are common and can influence drug absorption, metabolism, and clinical effects, potentially impacting health outcomes. Moreover, drug abuse can disrupt circadian metabolic profiles, increasing the risk of metabolic dysfunctions and diseases like metabolic syndrome. Addressing nutritional needs in substance use disorder (SUD) recovery programs can aid in faster recovery, reduce the risk of relapse, and improve overall health outcomes.
What is the process used to induce senescence in epidermal cells?
5 answers
Inducing senescence in epidermal cells involves the activation of p14^ARF, which leads to apoptosis, cell-cycle arrest, and subsequent p53-dependent senescence. This process requires continued expression of p14^ARF to commit cells to senescence, indicating a dependency on a persistent signal. Senescent cells formed in the epidermis are retained for extended periods even after transgene silencing, suggesting a lack of efficient removal mechanisms. Interestingly, epidermal hyperplasia induction can prevent the appearance of senescent cells upon p14^ARF activation. Understanding the dynamics of senescence induction in epidermal cells is crucial due to its implications in aging, tumor suppression, and tissue function.
What is the leukemia?
5 answers
Leukemia is a heterogeneous group of hematological malignancies characterized by the abnormal proliferation of lymphoid or hematopoietic cells in the bone marrow and other parts of the body. It is the 10th most common human malignancy, with over 60,000 new cases diagnosed annually in the United States. There are four main types of leukemia: Acute lymphoblastic leukemia (ALL), Acute myeloid leukemia (AML), Chronic lymphocytic leukemia (CLL), and Chronic myeloid leukemia (CML). Leukemia can affect individuals of all ages, but it is more prevalent in adults over 55 years old. Advances in leukemia research have led to improved understanding of the disease's biology, genetics, classification, and treatment options, resulting in enhanced clinical management and survival outcomes.
Why nurses avoid addressing existential or spiritual needs?
5 answers
Nurses may avoid addressing existential or spiritual needs due to various barriers identified in the literature. These barriers include high workload, lack of resources and time, task-oriented care missing opportunities to meet spiritual needs, lack of confidence/competence in delivering spiritual care, complexities in assessing and documenting spirituality, and lack of training. Additionally, a study on NHS nurses revealed that the degree to which nurses explore existential concerns with patients varies, influenced by factors such as ease in addressing these concerns, perceived benefits, and expectations. Furthermore, nursing students perceive their training on spiritual care to be deficient, expressing the need for strategies to address shortcomings in providing effective spiritual care, such as through art therapy. These factors collectively contribute to nurses avoiding addressing existential or spiritual needs in patient care.
How bladder cancer grade heterogeneity impact patients outcome?
9 answers
Bladder cancer (BCa) exhibits significant heterogeneity, both between patients (inter-patient) and within individual tumors (intra-tumor), which profoundly impacts patient outcomes. Studies have shown that the degree of heterogeneity within a tumor, particularly the presence of mixed-grade non-muscle invasive bladder cancer (NMIBC), does not significantly predict recurrence rates, although the overall recurrence rate for mixed-grade tumors remains high. This suggests that while grade heterogeneity is a notable feature of bladder cancer, its direct impact on recurrence may not be as significant as previously thought, necessitating further research for clear stratification and treatment implications. Moreover, the molecular landscape of bladder cancer, characterized by varying levels of intra-tumor subtype heterogeneity, has been linked to patient prognosis. For instance, a higher class 2a weight estimated from bulk RNA-sequencing data is associated with worse outcomes in patients with molecular high-risk class 2a tumors. This indicates that molecular characteristics, including subtype heterogeneity, can serve as important prognostic factors. The development of a prognostic signature based on 15 genes involved in the extracellular matrix-associated pathway further underscores the importance of molecular heterogeneity in predicting BCa patient outcomes. This signature effectively separates patients into groups with favorable and poor prognoses, highlighting the potential for molecular classification to guide prognosis and treatment. Additionally, the mutational spectrum and intratumor heterogeneity (ITH) of bladder cancer, as measured by the mutant-allele tumor heterogeneity (MATH) algorithm, correlate with clinical parameters and mutational subtypes, affecting therapy resistance and survival outcomes. For example, patients with FGFR3 mutations and low MATH values exhibit longer overall survival, suggesting that measures of tumor heterogeneity could serve as useful biomarkers for prognosis. In summary, bladder cancer grade heterogeneity, particularly when considered alongside molecular and genetic heterogeneity, plays a critical role in influencing patient outcomes. The complexity of bladder cancer's heterogeneity necessitates a multifaceted approach to prognosis and treatment, leveraging molecular classifications and genetic markers to tailor therapeutic strategies.